AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05440786 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: Orally
Study NCT05385328 — intervention group
Intervention type: DEVICE
Intervention: EYEFUL: healthy people
Description: This kind of study implies that we do not require the use of any substance, medicine or therapeutic technique and neither imply any risk to the participants.~The data to be captured are exclusively video and audio recordings, and different signals from smart watches (mainly related to movement). Addittionaly, the clinical evaluation of the performance of these activities will be carried out according to the assessment scales to be defined in the project. The results of this evaluation will be exclusively used in the training of the automatic systems developed in the project and in order to establish a correlation between the captured observations (video, audio, smart watches signals) and the diagnostic assessment.
Study NCT05385328 — intervention group
Intervention type: DEVICE
Intervention: EYEFUL: people with pathology
Description: This kind of study implies that we do not require the use of any substance, medicine or therapeutic technique and neither imply any risk to the participants.~The data to be captured are exclusively video and audio recordings, and different signals from smart watches (mainly related to movement). Addittionaly, the clinical evaluation of the performance of these activities will be carried out according to the assessment scales to be defined in the project. The results of this evaluation will be exclusively used in the training of the automatic systems developed in the project and in order to establish a correlation between the captured observations (video, audio, smart watches signals) and the diagnostic assessment.
Study NCT04746040 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Test
Description: 2 inhalations of Test and Reference product in each study period
Study NCT04746040 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Reference
Description: 2 inhalations of Test and Reference product in each study period
Study NCT05181657 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: COVID-19 education
Description: This session will be completed within 45 minutes. The LinkUP intervention will be available in English and Spanish.
Study NCT05181657 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: COVID-19 education
Description: This session will be completed within 45 minutes. The LinkUP intervention will be available in English and Spanish.
Study NCT06466265 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DNP002
Description: Anti-CEACAM6 monoclonal antibody
Study NCT06495151 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Mannose-binding lectin-associated serine protease-3 (MASP-3) Level
Description: Measurement of venous blood serum and peritoneal fluid levels of MASP-3 level by ELISA method.
Study NCT06495151 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Adipsin Level
Description: Measurement of venous blood serum and peritoneal fluid levels of adipsin level by ELISA method.
Study NCT06495151 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Properdin Level
Description: Measurement of venous blood serum and peritoneal fluid levels of properdin level by ELISA method.
Study NCT06495151 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Complement Factor H (CFH) Level
Description: Measurement of venous blood serum and peritoneal fluid levels of CFH level by ELISA method.
Study NCT06495151 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cancer Antigen 125 (CA-125) Level
Description: Measurement of venous blood serum level of CA-125 level by ELISA method.
Study NCT05207267 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: driving pressure guided tidal volume
Description: Volume control mode without spontaneous breathing, PEEP will be set according to best respiratory compliance method, and tidal volume (VT) will be set to reach three levels of driving pressure (High 14-15cmH2O, moderate 10-11 cmH2O, and low 7-8 cmH2O). Each level of VT was maintained 10 minutes in supine and/or prone position.
Study NCT05408169 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Planning sheet
Description: A planning tool presented on a separate single sheet of paper inserted into the screening invitation envelope. The colour illustrated tool prompts participants to identify concerns they have with using the bowel screening kit and to link them to a tip to help them overcome this concern.
Study NCT05318690 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PlayGait
Description: PlayGait is a dynamic energy storing and returning lower-limb exoskeleton.
Study NCT05318690 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Baseline
Description: Baseline condition with no prescribed or intervention lower-limb devices.
Study NCT04909021 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Investigational RSV vaccine MV-012-968 (Dosage 1)
Description: Single dose administered intranasally on Day 1
Study NCT04909021 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Investigational RSV vaccine MV-012-968 (Dosage 2)
Description: Single dose administered intranasally on Day 1
Study NCT04909021 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Investigational RSV vaccine MV-012-968 (Dosage 3; single-dose)
Description: Single dose administered intranasally on Day 1
Study NCT04909021 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Investigational RSV vaccine MV-012-968 (Dosage 3; two-dose)
Description: Single dose administered intranasally on Day 1, followed by an identical dose administered intranasally at the Day 29 study visit
Study NCT04909021 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (single-dose)
Description: Single dose administered intranasally on Day 1
Study NCT04909021 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (two-dose)
Description: Single dose administered intranasally on Day 1, followed by an identical dose administered intranasally at the Day 29 study visit
Study NCT06428773 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Participants were randomly divided into two groups: the exercise group and the control group. The exercise group performed moderate-intensity aerobic exercise on a stationary bicycle ergometer for 30 minutes during hemodialysis sessions, three days a week over 12 weeks. Additionally, the exercise group engaged in walking exercise for 30 minutes, three days a week outside of hemodialysis sessions, maintaining the heart rate between 50-60%. The exercise group also performed isolated exercises to expand wrist vessels, including wrist and elbow flexion, extension, and rotation, repeated 10 times, 2-3 days a week outside of hemodialysis sessions.
Study NCT06428773 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Participants were randomly divided into two groups: the exercise group and the control group. The exercise group performed moderate-intensity aerobic exercise on a stationary bicycle ergometer for 30 minutes during hemodialysis sessions, three days a week over 12 weeks. Additionally, the exercise group engaged in walking exercise for 30 minutes, three days a week outside of hemodialysis sessions, maintaining the heart rate between 50-60%. The exercise group also performed isolated exercises to expand wrist vessels, including wrist and elbow flexion, extension, and rotation, repeated 10 times, 2-3 days a week outside of hemodialysis sessions.
Study NCT05661383 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Non-invasive brain stimulation protocol (intermittent theta burst protocol (iTBS)) combined with pleasant odors delivered during the iTBS procol.
Description: Device: MagPro X100 (MagVenture, Mag2Health, France) iTBS protocol targeting the left dorsolateral prefrontal cortex: 50 consecutive sessions allocated on 10 days (i.e., 5 sessions per working day, 1 hour apart, for 2 weeks).~One iTBS session: burst of 3 pulses at 50 Hz repeated at 200 ms intervals for 2 s (i.e., at 5 Hz) at an intensity of 90% of rMT. A 2 s train of iTBS will be repeated every 10 s for a total of 1800 pulses per session.~Pleasant odorants will be delivered using passive diffusers placed in the room dedicated to the iTBS protocol, during the all-treatment duration. During the inclusion phase, 10 odors known to be pleasant will be presented to the subject. The 3 best rated by the subject will be chosen for olfactory stimulations. During the iTBS session, a randomly selected odor from the 3 will be presented at the same time as the iTBS treatment.
Study NCT05661383 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Non-invasive brain stimulation protocol (intermittent theta burst protocol (iTBS)) delivered alone.
Description: Device: MagPro X100 (MagVenture, Mag2Health, France) iTBS protocol targeting the left dorsolateral prefrontal cortex: 50 consecutive sessions allocated on 10 days (i.e., 5 sessions per working day, 1 hour apart, for 2 weeks).~One iTBS session: burst of 3 pulses at 50 Hz repeated at 200 ms intervals for 2 s (i.e., at 5 Hz) at an intensity of 90% of rMT. A 2 s train of iTBS will be repeated every 10 s for a total of 1800 pulses per session.
Study NCT04479761 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Visual and Auditory Cues
Description: Within each scene there will be 2 levels of visual input (static or dynamic) combined with 3 levels of sounds (static, none or dynamic). Postural responses to each combination will be evaluated in order to assess the role of generated and natural sounds in postural control and whether static sounds can improve balance within dynamic virtual environments.
Study NCT06060145 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Plants placed in an office environment
Description: The intervention group will be provided with an intervention consisting of 34-38 potted plants arranged in an office environment for a duration of 8 hours (09:00-17:00) on weekdays (Monday to Friday) for 4 weeks.
Study NCT06060145 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Devoid of any plant presence in an office environment
Description: Participants assigned to the control group will be exposed to an office environment devoid of any plant presence for a duration of 8 hours (09:00-17:00) on weekdays (Monday to Friday) for 4 weeks.
Study NCT05646381 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pelacarsen (TQJ230) 80mg
Description: Pelacarsen (TQJ230) 80mg
Study NCT05646381 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Matching placebo
Description: Matching placebo
Study NCT05508789 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donanemab
Description: Administered IV
Study NCT06485323 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MRI pelvimetry
Description: MRI of the pelvis
Study NCT05305092 — intervention group
Intervention type: DEVICE
Intervention: PET/MRI, psychobehavioral tests and questionnaires, serum biomarkers and stool sample
Description: Neuroimaging data were collected by integrated PET/MRI machine, and collected the psychobehavioral data, the serum and stool samples of participants.
Study NCT06627868 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: NAD+ precursor
Description: NAD+ precursor supplementation (Nicotinamide, Nicotinamide Riboside, or Nicotinamide Mononucleotide)
Study NCT05508789 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered IV
Study NCT06627868 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral placebo daily intake for 6 months
Study NCT06513832 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The asthma navigator
Description: The asthma navigator is a Registered Respiratory Therapist and Certified Asthma Educator who will review the care plan at discharge and provide asthma education; assist with follow-up clinic appointment scheduling, medication access, and transportation; and daily as-needed telephone support.
Study NCT05161780 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lactated Ringer's Irrigation
Description: Lactated Ringers at 40C will be used for the entirety of the surgery including the approach and exposure of the tumor as well as tumor resection, After surgery, two blinded skull base surgeon reviewers will rate the clarity of the endoscopic field of view at the recorded intervals. The surgical field will be graded using a widely accepted numeric integer (Boezaart) scale.
Study NCT05999305 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Teaching the critical care nursing course with an Escape Room game
Description: A teacher will begin with a 1.5-hour lecture, followed by an escape room game to reinforce learning through case studies for another 1.5 hours. The first section of the game will be a ten-minute pre-brief. The game will then begin promptly at a designated time and will be played in groups of six to seven students, with each group seated separately in a classroom. The game will last up to fifty minutes, during which all groups will be assisted to complete puzzles within the time limit. After the game, a fifteen-minute debriefing session will be held by the teacher, during which the students will reflect on their performance and what they learned about the cases and related topics. The teacher will finally provide feedback and support to the groups during this session.
Study NCT05999305 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Teaching the critical care nursing course with a case-based learning
Description: Students in the comparison group will also receive a 1.5 hour lecture which is the same as those in the intervention group. Another 1.5 hour is a case-based learning session, with six sessions in total over six weeks. The case-based learning sessions will include a pre-brief, teamwork, and debrief, and will be facilitated by the same teacher and teaching assistant and will primarily be provided with paper-based case studies.
Study NCT04992286 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: questionnaire
Description: questionnaire to evaluate fragility
Study NCT04992286 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: accelerometer
Description: To evaluate physical activity level
Study NCT05675033 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Serplulimab and Bevacizumab injection
Description: Serplulimab, 4.5mg/kg, intravenous injection, D1,Q21, until the disease progressed or showed intolerable side effects.~Bevacizumab injection, 7.5mg/kg, intravenous injection, D1, Q21, until the disease progressed or showed intolerable side effects.~Platinum-based chemotherapy: pemetrexed combined with carboplatin, D1-2, Q21, a total of 4 cycles.
Study NCT04559386 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey
Description: Questionnaire
Study NCT05513976 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR4640 tablet
Description: SHR4640 tablet 5mg
Study NCT05513976 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR4640 tablet
Description: SHR4640 tablet 10mg
Study NCT06352515 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Flow cytometry
Description: flow cytometry to study distribution of T lymphocyte subsets in ulcerative colitis patients
Study NCT05513976 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: febuxostat tablet
Description: febuxostat tablet 40mg or 60mg or 80mg based on prior medication
Study NCT05513976 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: febuxostat tablet
Description: febuxostat tablet 40mg or 60mg or 80mg based on prior medication
Study NCT05513976 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: SHR4640 placebo tablet
Description: SHR4640 placebo tablet 5 or 10mg
Study NCT05694676 — intervention group
Intervention type: OTHER
Intervention: Assessment of the quality of Genaral Movements (GMs)
Description: The variation, complexity and fluency of movements over a video recording is done and the quality of GMs is classified as normal-optimal, normal-suboptimal, mildly abnormal, and definitely abnormal movements.
Study NCT05694676 — intervention group
Intervention type: OTHER
Intervention: State-Trait Anxiety Inventory-Trait, (STAI-T)
Description: The scale consists of 20 items in total and provides a four-point Likert type measurement (1- anxiety symptom is not present, 4- the symptom lasts all the time). Scores range from 20 (low anxiety) to 80 (high anxiety).
Study NCT05694676 — intervention group
Intervention type: OTHER
Intervention: Beck Depression Inventory, (BDI)
Description: BDI contains 21 items and rates the depressive symptoms for the last week. Each item has four options and is scored between 0 and 3. The total score ranges from 0 to 63. Higher scores indicate more severe depression
Study NCT04013841 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Oral-agents/Enema
Description: 1. Oral-agents for mechanical bowel preparation prior to left-side colorectal resection~2. Enema for mechanical bowel preparation prior to left-side colorectal resection
Study NCT06627569 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: 12 weeks of aerobic exercise, with 4 sessions per week.
Study NCT06627829 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Surgically facilitated orthodontics therapy (SFOT) using allograft
Description: Participants will receive Surgically facilitated orthodontics therapy (SFOT) along with bone grafting using particulate allograft and collagen membrane, prior to orthodontics treatment.
Study NCT06627829 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Surgically facilitated orthodontics therapy (SFOT) using xenograft
Description: Participants will receive SFOT using particulate xenograft and collagen membrane, prior to orthodontics treatment.
Study NCT06627829 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Participants will have conventional orthodontics treatment with Invisalign aligners, without any surgical intervention
Study NCT05252377 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Breathing Exercise
Description: 1. The patient will be asked to close their eyes~2. He will be asked to relax his head and neck in a semi-sitting position in bed~3. The patient will be asked to breathe through the nose for 3 seconds by counting~4. Then he will be told to hold his breath for 3 seconds~5. As the last step, he will be asked to breathe out again in 3 seconds.
Study NCT06741852 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: nCLE assisted endobronchial ultrasound-guided transbronchial mediastinal cryobiopsy via a tunnel
Description: Patients received 2.5mL of 10% Fluorescite intravenously during nCLE. The CLE probe was preloaded into a puncture dilation catheter and locked into position with 2mm being exposed beyond the tip. puncture dilation catheter. The lymph node was punctured and the needle positioned at its center. The probe was advanced and locked, and the needle was advanced to the contralateral edge of the lymph node. Image acquisition began at the lymph node capsule, and then the subcapsular region, followed by the cortical sinus. When the image showed granuloma or malignant characteristics, the location will be recorded in EBUS, and retract the CLE probe, leaving the sheath of puncture dilation catheter as a tunnel between airway wall and target lymph node. Then, a 1.1-mm cryoprobe was inserted into the target lymph node through this tunnel under the EBUS guidance. The probe was cooled with liquid carbon dioxide for 5-9 seconds. Then retracted with the bronchoscope and the frozen biopsy tissue.
Study NCT06741852 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endobronchial ultrasound-guided transbronchial mediastinal cryobiopsy via a tunnel
Description: First a tunnel between airway wall and mediastinal and/or hilar lesion was made by a puncture dilation catheter (BroncTruTM AK-91-55, Broncus Inc. Hangzhou, China). The 1.1mm cryoprobe (Erbe 20402-401, ERBE, Tübingen, Germany) entered the target lymph node through the tunnel under direct monitoring of EBUS, and the distance between the tip of the cryoprobe and the border of target lymph node was measured using EBUS. After confirming that the distance was >5 mm, the probe was cooled with liquid carbon dioxide for 5-9 seconds. Then retracted with the bronchoscope and the frozen biopsy tissue. Samples were retrieved by thawing in saline and then fixed in formalin. The same lymph node was operated for 3 times.
Study NCT06742489 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Percutaneous tibial nerve stimulation device
Description: T-PTNS primarily delivers electrical stimulation to the sacral voiding center via the tibial nerve through the S2-S4 sacral plexus via skin-surface electrodes to improve patients' symptoms of urinary frequency, urgency, and urge incontinence.
Study NCT06742489 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham group device
Description: The device in the sham group is manufactured by the same company and has the same appearance, display interface, and operation method as the device in the treatment group. These devices have the output circuit disconnected and no actual current output.
Study NCT06741800 — intervention group
Intervention type: DRUG
Intervention: ACARIZAX®️
Description: ACARIZAX®️：The recommended dose for adults (18-65 years) is one freeze-dried tablet (12 SQ-HDM) daily, placed under the tongue.
Study NCT06742372 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: combined inspiratory and aerobic exercise training
Description: combined inspiratory and aerobic exercise training will be performed in healthy individuals
Study NCT05142085 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: nano-PSO
Description: This active treatment will be delivered to 3 out of 5 patients
Study NCT05142085 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: placebo
Description: This treatment will be assigned to 2 out of 5 patients
Study NCT06742372 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: aerobic exercise training
Description: aerobic exercise training will be performed in healthy individuals